Mercy Southeast introduces Aquablation Therapy for enlarged prostates

CAPE GIRARDEAU, Mo., (KBSI) — Mercy Southeast has introduced Aquablation therapy, a new procedure for treating enlarged prostates, marking the first of its kind in the Southeast Missouri region.

The treatment addresses lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH), a common condition affecting half of men aged 51-60 and becoming increasingly prevalent with age.

Aquablation therapy utilizes the HYDROS Robotic System, an FDA-cleared device combining imaging, robotics and heat-free waterjet ablation for targeted prostate tissue removal.

According to Dr. Mitch Ogles, a urologist, this procedure offers significant symptom relief while minimizing the risk of complications such as incontinence and erectile dysfunction.

BPH can cause urinary problems, and surgery is often recommended when lifestyle changes and medications are ineffective. Untreated BPH can lead to kidney and bladder damage, bladder stones and incontinence.

Surgeons use ultrasound imaging and cystoscopic visualization to create personalized treatment plans, guiding the robotic waterjet to remove excess tissue while avoiding critical structures. Clinical studies have demonstrated predictable and reproducible outcomes with Aquablation therapy.